ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionGreat Lakes Advisors, Llc
Latest Disclosed Ownership1,225 shares
Latest Disclosed Value $ 274,988
Great Lakes Advisors, Llc reports 0.57% increase in ownership of RMD / ResMed Inc.

On May 11, 2026 - Great Lakes Advisors, Llc filed a 13F-HR form disclosing ownership of 1,225 shares of ResMed Inc. (MX:RMD) valued at $274,988 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,218 shares of ResMed Inc.. This represents a change in shares of 0.57% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ResMed COM 761152107 1,225 7 0.57 275 -6.48 0.0007
2026-02-12 2025-12-31 13F ResMed COM 761152107 1,218 -52 -4.09 293 -15.56 0.0024
2025-11-03 2025-09-30 13F ResMed COM 761152107 1,270 -385 -23.26 348 -18.54 0.0029
2025-08-11 2025-06-30 13F ResMed COM 761152107 1,655 -13 -0.78 427 14.21 0.0036
2025-05-16 2025-03-31 13F ResMed COM 761152107 1,668 80 5.04 373 2.75 0.0033
2025-02-10 2024-12-31 13F ResMed COM 761152107 1,588 -59 -3.58 363 -9.70 0.0031
2024-11-04 2024-09-30 13F ResMed COM 761152107 1,647 -24 -1.44 402 26.02 0.0034
2024-08-06 2024-06-30 13F ResMed COM 761152107 1,671 -252 -13.10 320 -16.05 0.0028
2024-05-08 2024-03-31 13F ResMed COM 761152107 1,923 67 3.61 381 19.12 0.0032
2024-02-08 2023-12-31 13F ResMed COM 761152107 1,856 -787 -29.78 319 -18.21 0.0030
2023-11-07 2023-09-30 13F ResMed COM 761152107 2,643 68 2.64 391 -30.60 0.0036
2023-08-10 2023-06-30 13F ResMed COM 761152107 2,575 -3,033 -54.08 563 -54.23 0.0056
2023-05-10 2023-03-31 13F ResMed COM 761152107 5,608 -112 -1.96 1,228 3.19 0.0112
2023-02-09 2022-12-31 13F ResMed COM 761152107 5,720 -5,661 -49.74 1,191 -52.09 0.0682
2022-11-09 2022-09-30 13F ResMed COM 761152107 11,381 -44 -0.39 2,484 3.72 0.0542
2022-08-09 2022-06-30 13F ResMed COM 761152107 11,425 -787 -6.44 2,395 -19.14 0.0473
2022-05-06 2022-03-31 13F ResMed COM 761152107 12,212 -88 -0.72 2,962 -7.55 0.0379
2022-02-09 2021-12-31 13F ResMed COM 761152107 12,300 66 0.54 3,204 -0.62 0.0488
2021-11-09 2021-09-30 13F ResMed COM 761152107 12,234 707 6.13 3,224 13.44 0.0503
2021-08-11 2021-06-30 13F ResMed COM 761152107 11,527 -35 -0.30 2,842 26.71 0.0429
2021-05-03 2021-03-31 13F ResMed COM 761152107 11,562 -4,372 -27.44 2,243 -33.78 0.0362
2021-02-09 2020-12-31 13F ResMed COM 761152107 15,934 4,052 34.10 3,387 66.27 0.0613
2020-11-04 2020-09-30 13F ResMed COM 761152107 11,882 -17 -0.14 2,037 -10.85 0.0431
2020-08-07 2020-06-30 13F ResMed COM 761152107 11,899 -978 -7.59 2,285 20.45 0.0554
2020-05-08 2020-03-31 13F ResMed COM 761152107 12,877 -1,046 -7.51 1,897 -12.09 0.0554
2020-02-07 2019-12-31 13F ResMed COM 761152107 13,923 -82 -0.59 2,158 14.06 0.0463
2019-11-06 2019-09-30 13F ResMed COM 761152107 14,005 123 0.89 1,892 11.69 0.0415
2019-08-05 2019-06-30 13F ResMed COM 761152107 13,882 320 2.36 1,694 20.14 0.0369
2019-05-07 2019-03-31 13F ResMed COM 761152107 13,562 -310 -2.23 1,410 -10.76 0.0314
2019-02-13 2018-12-31 13F ResMed COM 761152107 13,872 -964 -6.50 1,580 -7.66 0.0374
2018-11-30 2018-09-30 13F/A-2 ResMed COM 761152107 14,836 -171,669 -92.05 1,711 -91.14 0.0378
2018-11-14 2018-09-30 13F RESMED COM 761152107 186,505 0 19,318
2018-08-13 2018-06-30 13F RESMED COM 761152107 186,505 3,633 1.99 19,318 7.28 0.4528
2018-05-07 2018-03-31 13F RESMED CS 761152107 182,872 72,344 65.45 18,007 92.36 0.4289
2018-02-07 2017-12-31 13F RESMED CS 761152107 110,528 21,054 23.53 9,361 35.94 0.2058
2017-11-13 2017-09-30 13F RESMED CS 761152107 89,474 89,474 6,886 0.1620
2017-08-07 2017-06-30 13F RESMED CS 761152107 0 -3,267 -100.00 0 -100.00
2017-05-09 2017-03-31 13F RESMED CS 761152107 3,267 3,267 235 0.0060
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.